Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eucerin AtopiControl for Atopic Dermatitis with Pollen Challenge
NCT03315611Completed
- Sponsor
- Fraunhofer ITEM
- Start
- Oct 2017
- Primary completion
- Apr 2018
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
Randomised, single-blind trial of eucerin atopicontrol in atopic dermatitis (AD) (3 arms), sponsored by Fraunhofer ITEM. Primary endpoint: SCORing Atopic Dermatitis at Day 3. Started Oct 2017; status: completed.
02
Drugs
eucerin atopicontrol
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03315611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03315611.